| NAME |
CIPROFLOXACIN HCL 500MG/5ML SUSP |
| VA GENERIC NAME |
CIPROFLOXACIN |
| DOSAGE FORM |
PWDR,RENST-ORAL |
| FDA MED GUIDE |
Ciprofloxacin_Susp_(Generic)_(Dec_2016).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
500 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MG/5ML |
| NATIONAL FORMULARY NAME |
CIPROFLOXACIN PWDR,RENST-ORAL |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
CIPROFLOXACIN HCL 500MG/5ML SUSP |
| VA PRODUCT IDENTIFIER |
C0838 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4013474 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
|
